Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

OGT launches breakthrough CytoSure NGS panel for constitutional cytogenetics

Friday, January 31, 2020

Oxford Gene Technology OGT A Sysmex Group Company has launched a transformative nextgeneration sequencing NGS panel for constitutional cytogenetics research The CytoSure Constitutional NGS Panel contains the most uptodate handcurated content for inte...

Vetter Aligns its Development Service Laboratory Portfolio Under One Roof

Friday, January 31, 2020

Vetter a global operating Contract Development and Manufacturing Organization CDMO has brought together its development laboratories in one Ravensburg site end of last year Designed to improve workflow and enhance customer benefits within the daily s...

Pulmatrix Receives Fast Track Designation for Pulmazole for the Treatment of Asthma-ABPA

Friday, January 31, 2020

Pulmatrix Inc announced that the US Food and Drug Administration FDA has granted Fast Track designation to PUR Pulmazole the Companys inhaled itraconazole antifungal candidate being developed to treat allergic bronchopulmonary aspergillosis ABPA in p...

Compugen Further Expands Intellectual Property Portfolio With New European Patent for Anti-PVRIG Antibodies

Thursday, January 30, 2020

Compugen Ltd a clinicalstage cancer immunotherapy company and leader in predictive target discovery announced today that The European Patent Office EPO has granted the Company a new patent for the use of any antiPVRIG antibody in the treatment of can...

Predictive Technology Group and Atrin Pharmaceuticals Announce Molecular Diagnostic Oncology Development Collaboration

Wednesday, January 29, 2020

Predictive Technology Group and Atrin Pharmaceuticals LLC are entering into a collaboration agreement to develop molecular diagnostic tools to facilitate improved selection of cancer patients who would most benefit from treatment with DNA Damage and...

SAGA Diagnostics Extends its Collaboration with Servier to Use Ultrasensitive SAGAsafe® Technology in Cancer Clinical Trials

Wednesday, January 29, 2020

SAGA Diagnostics AB a cancer liquid biopsy and genomic testing company focused on precision oncology and noninvasive ultrasensitive monitoring of cancer patients today announces it has entered service agreements with the international pharmaceutical...

Ningbo NewBay Medical Technology Co., Ltd. Announces a License Agreement with Genentech

Tuesday, January 28, 2020

Ningbo NewBay Medical Technology Co Ltd a subsidiary of Ningbo Tai Kang Medical Technology Co Ltd announced today that it has entered into a licensing agreement with Genentech a member of the Roche Group under which it has been granted the exclusive...

FDA Approves Merck’s DIFICID® (fidaxomicin) to Treat Clostridioides difficile in Children Aged Six Months and Older

Tuesday, January 28, 2020

Merck known as MSD outside the United States and Canada today announced the US Food and Drug Administration FDA has approved a New Drug Application NDA for DIFICID fidaxomicin for oral suspension and a supplemental New Drug Application sNDA for DIFIC...

Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV

Monday, January 27, 2020

Sirnaomics Inc Sirnaomics a leading biopharmaceutical company in discovery and development of novel RNAi therapeutics announced today that it has mobilized its research teams both in USA and China to develop novel RNAibased prophylactics and therapeu...

European CNS Specialist Neuraxpharm Strengthens Expansion into Austrian Market with Acquisition of easypharm

Friday, January 24, 2020

Neuraxpharm Group Neuraxpharm a leading European specialty pharmaceutical company focused on central nervous system CNS disorders today announces the expansion of its operations in Central Europe with the launch of Neuraxpharm Austria and the acquisi...